Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Coll Cardiol ; 34(1): 113-21, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10399999

ABSTRACT

OBJECTIVES: The purpose of this study was to determine whether antianginal medications modify the prognostic significance of exercise single photon emission computed tomography (SPECT) ischemia. BACKGROUND: Antianginal medications (especially beta-adrenergic blocking agents) limit exercise SPECT ischemia, but it is not known whether such medications also modify the prognostic effect of exercise SPECT ischemia. METHODS: We included 352 patients with coronary heart disease, who had exercise Tl-201 SPECT and coronary angiography, and who were initially treated medically. Survival Cox models were applied in patients for whom classes of antianginal medications taken at exercise SPECT were the same as those prescribed for follow-up (GI; n = 136), and in patients for whom new classes of antianginal medications, including beta-blockers (GII; n = 79) or not including beta-blockers (GIII; n = 113), were added for follow-up. RESULTS: During a mean 5.3+/-1.6 years of follow-up, 45 patients had cardiac death or myocardial infarction. Variables reflecting necrosis (irreversible defect extent, left ventricular ejection fraction) and those from coronary angiography provided equivalent prognostic information in the three groups. In contrast, the SPECT variable reflecting ischemia (reversible defect extent), which provided comparable prognostic information in GI (p = 0.005) and GIII (p = 0.004), lost its prognostic significance (p = 0.54) in GII, and was associated with a lower relative risk in GII than in GI or GIII (both p < 0.05). CONCLUSIONS: In patients with coronary heart disease, the introduction of antianginal medications, when including beta-blockers, appears to have a favorable effect on the deleterious prognostic effect of exercise ischemia.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/drug therapy , Thallium Radioisotopes , Tomography, Emission-Computed, Single-Photon , Aged , Calcium Channel Blockers/therapeutic use , Exercise Test , Female , Humans , Male , Middle Aged , Molsidomine/therapeutic use , Nitrates/therapeutic use , Prognosis , Regression Analysis , Retrospective Studies , Treatment Outcome , Vasodilator Agents/therapeutic use
2.
Clin Cardiol ; 20(4): 407-10, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9098605

ABSTRACT

This paper reports on three cases of patients with an apparently normal heart admitted for sustained monomorphic ventricular tachycardia. The only abnormal finding showed in the electrocardiogram (ECG) in sinus rhythm that exhibited an entity associated with incomplete right bundle-branch block and persistent ST-segment elevation. The ECG entity was variable and disappeared transiently. Spontaneous ventricular tachycardia in one patient was inducible by programmed stimulation. There was no underlying heart disease. The origin of the ventricular tachycardia in one patient was located by pace mapping in the left ventricle at the left ventricular basal septum. The follow-up (from 6 months up to 6 years) demonstrated a good prognosis. This particular ECG entity associated with monomorphic ventricular tachycardia could have been missed because of the variations in the ECG in sinus rhythm and was associated with a favorable prognosis.


Subject(s)
Bundle-Branch Block/diagnosis , Electrocardiography , Tachycardia, Ventricular/diagnosis , Adult , Aged , Anti-Arrhythmia Agents/therapeutic use , Bundle-Branch Block/drug therapy , Bundle-Branch Block/physiopathology , Cardiac Pacing, Artificial , Follow-Up Studies , Heart Conduction System/physiopathology , Humans , Male , Middle Aged , Syndrome , Tachycardia, Ventricular/drug therapy , Tachycardia, Ventricular/physiopathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...